Literature DB >> 19387341

Multiple sclerosis and the major histocompatibility complex.

Sreeram V Ramagopalan1, Julian C Knight, George C Ebers.   

Abstract

PURPOSE OF REVIEW: Multiple sclerosis (MS) is the most common neurological disease affecting young adults. The cause is unknown, but detailed epidemiological and genetic studies have shown a clear inherited component. We review here some of the recent findings of MS genetics with a particular focus on genes of the major histocompatibility complex (MHC). RECENT
FINDINGS: Recent studies add further complexity to the role of the MHC in MS. Reported MHC associations are complex, involving haplotypes rather than single alleles and may involve epigenetic mechanisms and other modulators of gene expression. MHC class II haplotypes display a hierarchy of risks, including protective effects and epistatic interactions, which together dwarf any non-MHC genetic effect. Genes in the MHC region have been shown to influence disease severity, display parent-of-origin effects and interact with a major environmental candidate for MS, vitamin D.
SUMMARY: The MHC class II association with MS is not as straightforward as previously thought. A complete understanding of the epistatic interactions and epigenetic features of this region will be important to understand disease pathogenesis and likely aid the discovery of new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387341     DOI: 10.1097/WCO.0b013e32832b5417

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  31 in total

1.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.

Authors:  Pierre-Antoine Gourraud; Joseph P McElroy; Stacy J Caillier; Britt A Johnson; Adam Santaniello; Stephen L Hauser; Jorge R Oksenberg
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 2.  The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models.

Authors:  Dimitry N Krementsov; Tina M Thornton; Cory Teuscher; Mercedes Rincon
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

3.  Multiple sclerosis: autoimmune associations in multiple sclerosis.

Authors:  Cris S Constantinescu; Bruno Gran
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

Review 4.  Brain dendritic cells: biology and pathology.

Authors:  Paul M D'Agostino; Andres Gottfried-Blackmore; Niroshana Anandasabapathy; Karen Bulloch
Journal:  Acta Neuropathol       Date:  2012-07-24       Impact factor: 17.088

5.  Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.

Authors:  Erin E Longbrake; David A Hafler
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

6.  Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.

Authors:  Marvin M van Luijn; Karim L Kreft; Marlieke L Jongsma; Steven W Mes; Annet F Wierenga-Wolf; Marjan van Meurs; Marie-José Melief; Rik van der Kant; Lennert Janssen; Hans Janssen; Rusung Tan; John J Priatel; Jacques Neefjes; Jon D Laman; Rogier Q Hintzen
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

Review 7.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

8.  NRAMP1 (SLC11A1) variants: genetic susceptibility to multiple Sclerosis.

Authors:  Omer Ates; Semiha Kurt; Nihan Bozkurt; Hatice Karaer
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

9.  Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.

Authors:  Antonio Alcina; Sreeram V Ramagopalan; Oscar Fernández; Antonio Catalá-Rabasa; María Fedetz; Dorothy Ndagire; Laura Leyva; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; George C Ebers; Fuencisla Matesanz
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

Review 10.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.